ppm) all to be shifted downfield.13 In the spectrum of (2S)-
7, the presence of the axial sulfoxide oxygen caused a similar
downfield shift of its tert-butyl ester singlet (1.61 ppm) and
C-6 â-proton (4.9 ppm). In the spectrum of (2R)-7, only the
PhF resonances (7.20-8.27 ppm) were shifted further
downfield by the presence of the equatorial sulfoxide oxygen,
and the signals for the tert-butyl ester singlet (1.40 ppm)
and C-6 â-proton (4.37 ppm) remained upfield. These
assignments also correlated with the fact that only the (2R)-
sulfamidite (2R)-7 was oxidized to sulfamidate 2, because
in sulfamidite (2S)-7, the S+-O- group sits in an axial
position and access of the oxidant to the sulfur was blocked
by the PhF group.
hexanes) was observed by TLC. Sodium azide and potassium
thiocyanate were used without additional NaH. The solution
was then cooled, poured into a 1 M NaH2PO4 solution, and
agitated to hydrolyze the sulfamic acid intermediate. The
desired γ-substituted R-N-(PhF)amino esters 9 were isolated
after extraction with EtOAc and column chromatography on
silica gel. Amine nucleophiles were later found to be
sufficiently reactive in the absence of NaH and provided
clean products after heating with 2 in acetonitrile at 70 °C
for 30 h. Phenolate and thiophenolate ions both reacted with
sulfamidate 2 to provide, respectively, O-phenylhomoserine
9i and S-phenylhomocysteine 9h. The related O-alkylho-
moserine and S-alkylhomocysteine analogues could not be
isolated from treatment of 2 with methoxide and benzylthi-
olate ions in preliminary experiments; instead, cursory
analyses of the reaction mixtures indicated decomposition
of sulfamidate 2.
Ring opening of sulfamidate 2 was examined using
nitrogen, sulfur, and oxygen nucleophiles (Table 1). In our
Table 1. Nucleophilic Opening of Sulfamidate 2
Scheme 2
entry
nucleophile
conditions
9 (%)
[R]20
D
a
b
NaN3
DMF, 60°, 24 h
NaH, DMF, 60°, 24 h
DMF, 60°, 24 h
83
50
56
65
85
95
80
90
85
91
68
56
0
-211°
-165°
-165°
-165°
-217°
-217°
-130°
-130°
-146°
-176°
-210°
-310°
imidazole
imidazole
imidazole
morpholine
morpholine
piperidine
piperidine
PhNH2
i-BuNH2
KSCN
PhSH
PhSH
PhOH
CH3CN, 75°, 30 h
NaH, DMF, 60°, 24 h
CH3CN, 75°, 30 h
DMF, 60°, 24 h
CH3CN, 75°, 30 h
CH3CN, 75°, 30 h
CH3CN, 75°, 30 h
CH3CN, 75°, 30 h
NaH, DMF, 60°, 24 h
CH3CN, 75°, 30 h
NaH, DMF, 60°, 60 h
c
d
e
f
g
h
i
56
-178°
Deprotection of γ-substituted R-N-(PhF)amino esters 9 was
demonstrated by treating piperidinyl analogue 9d with TFA
in dichloromethane for 18 h (Scheme 2). The trifluoroacetate
salt was obtained in acceptable purity by evaporation of the
volatiles, digestion of the residue into water, filtration of the
insoluble hydrocarbon, and evaporation of the aqueous phase.
Amino acid 10d was later isolated in zwiterionic form after
ion exchange chromatography.
initial procedure, sulfamidate 2 (100 mol %), the nucleophile
(2-300 mol %), and sodium hydride (2-300 mol %) were
heated in DMF at 60 °C for 24-48 h, when complete
consumption of starting material (Rf ) 0.3 in 1:3 EtOAc/
(8) A 0.05 M solution of N-(PhF)homoserine 6 (2 g, 4.7 mmol, prepared
according to ref 5) in dichloromethane was treated in the same manner as
described for the synthesis of serine-derived cyclic sulfamidites in ref 1.
Chromatography on silica gel with a gradient of 0-10% EtOAc in hexane
furnished 1.6 g (71%) of (2R,4S)-tert-butyl 2-oxo-3-PhF-1,2,3-oxathiaza-
inane-4-carboxylate (2R)-7 and 0.5 g (23%) of (2S)-7. First to elute was
(2S)-7: Rf ) 0.36 (30% EtOAc in hexanes); mp 166-167 °C; [R]20D 212°
(10) The same protocol described in ref 1 for the oxidation of serine-
derived sulfamidite to sulfamidate 1 was employed to convert (2R)-7 (500
mg) to 2. N-(PhF)homoserine-derived cyclic sulfamidate 2 (468 mg, 89%)
crystalized upon evaporation of the combined dried organic extractions:
1
(c 0.34, CHCl3); H NMR δ 1.26 (m, 1 H), 1.61 (s, 9 H), 1.78 (m, 1 H),
3.16 (dd, 1 H, J ) 2.5, 5.4), 3.53 (m, 1 H), 4.90 (m, 1 H), 7.19-7.77 (m,
13 H); 13C NMR δ 22.6, 27.9, 49.3, 54.6, 76.6, 81.7, 169.9; HRMS calcd
for C27H27O4NNaS (M + Na) 484.1559, found 484.1560. Second to elute
mp 188-188.5 °C; [R]20 268° (c 0.37, CHCl3); 1H NMR δ 1.10 (m, 1
D
H), 1.66 (s, 9 H), 1.74 (m, 1 H), 3.85 (br d, 1 H, J ) 5.3), 4.15 (m, 1 H),
4.88 (m, 1 H), 7.20-8.11 (m, 13 H); 13C NMR δ 22.4, 28.0, 58.3, 70.7,
78.6, 82.6, 168.3; HRMS calcd for C27H27O5NNaS (M + Na) 500.1508,
found 500.1489.
was (2R)-7: Rf ) 0.27 (20% EtOAc in hexanes); mp 172-173 °C; [R]20
D
132° (c 0.33, CHCl3); 1H NMR δ 1.40 (s, 9 H), 2.18 (m, 1 H), 2.69 (m, 1
H), 3.31 (dd, 1 H, J ) 3.4, 4.3), 3.94 (ddd, 1 H, J ) 9.7, 10.9, 16.4), 4.37
(m, 1 H), 7.20-8.27 (m, 13 H); 13C NMR δ 26.6, 27.8, 54.3, 57.0, 76.8,
81.3, 170.6; HRMS calcd for C27H27O4NNaS (M + Na) 484.1559, found
484.1541.
(11) (a) Reviewed in: Lohray, B. B. Synthesis 1992, 1035. (b) Wood,
G.; McIntosh, J. M.; Miskow, M Tetrahedron Lett. 1970, 4895.
(12) (a) Christie, B. D.; Rapoport, H. J. Org. Chem. 1985, 50, 1239. (b)
Swarbrick, M. E.; Gosselin, F.; Lubell, W. D. J. Org. Chem. 1999, 64,
1993. (c) Swarbrick, M. E.; Lubell, W. D. Chirality 2000, 12, 366.
(13) Deyrup, J. A.; Moyer, C. L. J. Org. Chem. 1969, 34, 175.
(9) HRMS calcd for C54H57O7N2S (MH+) 877.3887, found 877.3853.
Dimerization product 8 was best prevented under dilute conditions (0.05
M) using excess imidazole (400 mol %).
Org. Lett., Vol. 3, No. 19, 2001
2967